Most Read News

Agro Tech Foods Limited has informed the Exchange about Presentation

SMS Pharmaceuticals has received a non-exclusive license through the Medicines Patent Pool to manufacture molnupiravir, an investigational oral antiviral Covid- 19 medicine, to increase broad access of treatment in 105 low- and middle-income countries. Powered by Capital Market – Live News

TPL Plastech Limited has informed the Exchange about Loss of Share Certificates Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the share certificate mentioned in the attached letter have been lost reported by holder. The holder of this share has requested us to issue duplicate share certificate in lieu of the original. Kindly acknowledge receipt.

Net Sales up 10.33%

Strides Pharma Science today announced its partnership with Medicines Patent Pool (MPP) to commercialize molnupiravir in the international markets. Strides and its subsidiary, Universal Corporation (Kenya), have entered into a voluntary non?]exclusive sub?]license partnership with MPP covering 105 countries as part of MSD (NYSE: MRK, a trading name of Merck & Co., Inc, Kenilworth, NJ, USA) and MPP?fs partnership to enable a global reach for […]

With effect from 20 January 2022

CSB Bank Limited has informed the Exchange about change in the timing of conference call

Century Textiles & Industries Limited has informed the Exchange about Copy of Newspaper Publication

Birla Corporation Limited has informed the Exchange regarding a press release dated January 21, 2022, titled Integrated cement plant of RCCPL, wholly owned subsidiary of Birla Corporation Limited, inaugurated at Mukutban, taking Group capacity to 20 million tons.

Hotel Rugby Limited has informed the Exchange regarding In terms of Regulation 26(7) of the SEBI (SAST) Regulations, 2011, we enclose herewith written reasoned recommendation duly approved by the Committee of the Independent Directors at its meeting held on January 20, 2022 in respect of open offer of the Target Company. .